Published in Front Synaptic Neurosci on January 21, 2014
Programming of stress-related behavior and epigenetic neural gene regulation in mice offspring through maternal exposure to predator odor. Front Behav Neurosci (2015) 0.82
Rare DNA variants in the brain-derived neurotrophic factor gene increase risk for attention-deficit hyperactivity disorder: a next-generation sequencing study. Mol Psychiatry (2016) 0.75
Age-Dependent Effects of Methylphenidate on the Human Dopaminergic System in Young vs Adult Patients With Attention-Deficit/Hyperactivity Disorder: A Randomized Clinical Trial. JAMA Psychiatry (2016) 0.75
Preventative treatment in an animal model of ADHD: Behavioral and biochemical effects of methylphenidate and its interactions with ovarian hormones in female rats. Eur Neuropsychopharmacol (2016) 0.75
Editorial: Cell and molecular signaling, and transport pathways involved in growth factor control of synaptic development and function. Front Synaptic Neurosci (2015) 0.75
BDNF concentrations and daily fluctuations differ among ADHD children and respond differently to methylphenidate with no relationship with depressive symptomatology. Psychopharmacology (Berl) (2016) 0.75
Differences between adolescents and adults in the acute effects of PCP and ketamine and in sensitization following intermittent administration. Pharmacol Biochem Behav (2017) 0.75
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci (2006) 8.24
Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation. Proc Natl Acad Sci U S A (2007) 5.56
Mouse and rat BDNF gene structure and expression revisited. J Neurosci Res (2007) 4.13
Methylphenidate treatment during pre- and periadolescence alters behavioral responses to emotional stimuli at adulthood. Biol Psychiatry (2003) 2.37
Dopamine modulation of prefrontal cortical interneurons changes during adolescence. Cereb Cortex (2006) 2.10
Enduring behavioral effects of early exposure to methylphenidate in rats. Biol Psychiatry (2003) 2.08
A BDNF infusion into the medial prefrontal cortex suppresses cocaine seeking in rats. Eur J Neurosci (2007) 2.00
Elevated BDNF after cocaine withdrawal facilitates LTP in medial prefrontal cortex by suppressing GABA inhibition. Neuron (2010) 1.90
Exposure of adolescent rats to oral methylphenidate: preferential effects on extracellular norepinephrine and absence of sensitization and cross-sensitization to methamphetamine. J Neurosci (2002) 1.89
A set of differentially expressed miRNAs, including miR-30a-5p, act as post-transcriptional inhibitors of BDNF in prefrontal cortex. Hum Mol Genet (2008) 1.87
Second-order schedules of drug reinforcement in rats and monkeys: measurement of reinforcing efficacy and drug-seeking behaviour. Psychopharmacology (Berl) (2000) 1.77
Age of methylphenidate treatment initiation in children with ADHD and later substance abuse: prospective follow-up into adulthood. Am J Psychiatry (2008) 1.71
Altered responsiveness to cocaine in rats exposed to methylphenidate during development. Nat Neurosci (2002) 1.56
Cocaine-induced chromatin remodeling increases brain-derived neurotrophic factor transcription in the rat medial prefrontal cortex, which alters the reinforcing efficacy of cocaine. J Neurosci (2010) 1.47
Enhanced reactivity and vulnerability to cocaine following methylphenidate treatment in adolescent rats. Neuropsychopharmacology (2001) 1.46
A single cocaine exposure increases BDNF and D3 receptor expression: implications for drug-conditioning. Neuroreport (2005) 1.40
Epigenetic regulation of the BDNF gene: implications for psychiatric disorders. Mol Psychiatry (2011) 1.37
Pharmacokinetics of methylphenidate in man, rat and monkey. J Pharmacol Exp Ther (1983) 1.36
Developmental trajectories during adolescence in males and females: a cross-species understanding of underlying brain changes. Neurosci Biobehav Rev (2011) 1.35
Five-fold increase in national prevalence rates of attention-deficit/hyperactivity disorder medications for children and adolescents with autism spectrum disorder, attention-deficit/hyperactivity disorder, and other psychiatric disorders: a Danish register-based study. J Child Adolesc Psychopharmacol (2013) 1.31
Stimulants and the developing brain. Trends Pharmacol Sci (2005) 1.31
Quantitative autoradiographic mapping of rat brain dopamine D3 binding with [(125)I]7-OH-PIPAT: evidence for the presence of D3 receptors on dopaminergic and nondopaminergic cell bodies and terminals. J Pharmacol Exp Ther (2000) 1.20
Neuronal activity regulates the developmental expression and subcellular localization of cortical BDNF mRNA isoforms in vivo. Mol Cell Neurosci (2005) 1.19
Developmental differences in dopamine synthesis inhibition by (+/-)-7-OH-DPAT. Naunyn Schmiedebergs Arch Pharmacol (1997) 1.18
Dopamine D3 as well as D2 receptor ligands attenuate the cue-induced cocaine-seeking in a relapse model in rats. Drug Alcohol Depend (2005) 1.07
Distinct age-dependent effects of methylphenidate on developing and adult prefrontal neurons. Biol Psychiatry (2012) 1.07
BDNF-induced local protein synthesis and synaptic plasticity. Neuropharmacology (2013) 1.06
Selective blockade of dopamine D3 receptors enhances while D2 receptor antagonism impairs social novelty discrimination and novel object recognition in rats: a key role for the prefrontal cortex. Neuropsychopharmacology (2011) 1.06
Brain derived neurotrophic factor (BDNF) expression is regulated by microRNAs miR-26a and miR-26b allele-specific binding. PLoS One (2011) 1.01
Juvenile administration of concomitant methylphenidate and fluoxetine alters behavioral reactivity to reward- and mood-related stimuli and disrupts ventral tegmental area gene expression in adulthood. J Neurosci (2011) 1.00
The dopamine D3 receptor and drug addiction. Neurotox Res (2001) 0.95
Distinctive four promoters collectively direct expression of brain-derived neurotrophic factor gene. Brain Res Mol Brain Res (1994) 0.92
Chronic oral methylphenidate administration to periadolescent rats yields prolonged impairment of memory for objects. Neurobiol Learn Mem (2007) 0.89
Juvenile methylphenidate modulates reward-related behaviors and cerebral blood flow by decreasing cortical D3 receptors. Eur J Neurosci (2008) 0.89
Transient dopamine synthesis modulation in prefrontal cortex: in vitro studies. Brain Res Dev Brain Res (2004) 0.88
Sub-chronic exposure to atomoxetine up-regulates BDNF expression and signalling in the brain of adolescent spontaneously hypertensive rats: comparison with methylphenidate. Pharmacol Res (2010) 0.88
In vivo occupancy of dopamine D3 receptors by antagonists produces neurochemical and behavioral effects of potential relevance to attention-deficit-hyperactivity disorder. J Pharmacol Exp Ther (2012) 0.87
Methylphenidate regulates activity regulated cytoskeletal associated but not brain-derived neurotrophic factor gene expression in the developing rat striatum. Neuroscience (2006) 0.86
Epigenetics and psychostimulant addiction. Cold Spring Harb Perspect Med (2013) 0.86
Regulation of BDNF expression by cocaine. Yale J Biol Med (2012) 0.84
Juvenile methylphenidate exposure and factors that influence incentive processing. Dev Neurosci (2009) 0.84
Temporal and spatial differences in expression of TrkB isoforms in rat retina during constant light exposure. Exp Eye Res (2007) 0.82
Cell body infusions of brain-derived neurotrophic factor increase forebrain dopamine release and serotonin metabolism determined with in vivo microdialysis. Adv Pharmacol (1998) 0.82
Juvenile exposure to methylphenidate reduces cocaine reward and alters netrin-1 receptor expression in adulthood. Behav Brain Res (2012) 0.80
Behavioral responses to dopamine agonists in adult rats exposed to cocaine during the preweaning period. Pharmacol Biochem Behav (2001) 0.79
Actions of (+/-)-7-hydroxy-N,N-dipropylaminotetralin (7-OH-DPAT) on dopamine synthesis in limbic and extrapyramidal regions of rat brain. Brain Res (1994) 0.77